12:56 PM EDT, 06/26/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Wednesday its unit has struck a deal to buy shares of Northstar Switzerland SARL from Haleon ( HLN ) for 500 million British pounds ($632 million).

The firm said it would acquire Haleon's ( HLN ) global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy category outside of the US with the deal. The portfolio includes Nicotinell and local market brand names Nicabate, Thrive, and Habitrol.

It expects to close the transaction in early Q4 of 2024.

The company said the acquisition is as ideal anchor to continue to build its global consumer healthcare OTC business.

Price: 71.83, Change: +0.02, Percent Change: +0.03